HistoGenetics to Incorporate MiSeq into HLA Typing Workflow GenomeWeb HLA-typing firm HistoGenetics said this week that it has purchased 20 of Illumina's MiSeq systems that it will incorporate into its HLA typing workflow. HistoGenetics' CEO Nezih Cereb told Clinical Sequencing News that the MiSeqs will initially ... |